Clinical Trials Logo

Muscular Atrophy clinical trials

View clinical trials related to Muscular Atrophy.

Filter by:

NCT ID: NCT03204240 Completed - Clinical trials for Spinal Cord Injuries

Metabolic Health in Individuals With Spinal Cord Injury (SCI)

SCI
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Individuals with spinal cord injury (SCI) live longer than before and live to an age where metabolic disorders become highly prevalent. Due to loss of mobility and severe skeletal muscle atrophy, obesity, glucose intolerance, and peripheral insulin resistance develop soon after the onset of SCI. These abnormalities are thought to contribute to the increased diabetes disease risk and accelerated aging process in the SCI population. As a result of these trends, overall burden of complications, economic impact and reduced quality of life are increasing. Until there are effective treatments for SCI, it is imperative to develop effective interventions to mitigate metabolic disorders that develop in individuals with SCI. The proposed research project examines the impact of early utilization of a novel neuromuscular electrical stimulation (NMES) program on skeletal muscle metabolism and overall metabolic health in individuals with sub-acute, complete SCI.

NCT ID: NCT03195348 Completed - Sleep Disturbance Clinical Trials

The Effects of Whole Body Unloading on Physiological Function

Start date: March 29, 2017
Phase: N/A
Study type: Interventional

This study is a collaboration between the Centre of Human & Aerospace Physiological Sciences (CHAPS) and the Sleep and Brain Plasticity Centre (Department of Neuroimaging) at King's College London and the Sleep Disorders Centre at Guy's Hospital.The main purpose of the study is to evaluate the effects of a 7 day unloading period (simulating micro gravity) on muscle mass using three independent methodsÍž two scanning techniques (magnetic resonance imaging (MRI) and dual x-ray absorptiometry (DXA)) and one that involves swallowing a capsule that contains a harmless chemical called creatine (D3-Creatine (D3-cr)) and then measuring its concentration in urine. In order to induce muscle loss, participants will be required to lie flat on their back on a water bed filled with water and salt (called hyper-buoyancy flotation (HBF)). As this situation is similar to that experienced in space, the investigators will also measure the effect of HBF on sleep, brain and physiological function - all things known to change in astronauts. Sixteen male subjects (18-40 yrs) will be recruited to participate in the study that will require physiological testing before, during and following both 7 days of normal conditions and 7 days of HBF bed-rest. Each subject will be exposed to the same conditions and assessments over the study period. As some loss of muscle is expected, participants will be offered an exercise rehabilitation programme upon completion of HBF with self-monitored and/or guided sessions based on those provided by the Space Medicine Office of the European Space Agency to returning astronauts.

NCT ID: NCT03059836 Completed - Muscle Atrophy Clinical Trials

n3 PUFA and Muscle-disuse Atrophy in Young Women

Start date: February 28, 2017
Phase: N/A
Study type: Interventional

This study will examine the influence of n3 PUFA supplementation on the rate of muscle atrophy in women undergoing 2 weeks of unilateral limb immobilization. Assessments in skeletal muscle strength and skeletal muscle volume will also me made before, after and in recovery from immobilization.

NCT ID: NCT03051984 Completed - Knee Osteoarthritis Clinical Trials

Skeletal Muscle Atrophy and Dysfunction Following Total Knee Arthroplasty

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Total knee replacement, or arthroplasty, is the final clinical intervention available to relieve pain and functional limitations related to advanced stage knee osteoarthritis. Despite its beneficial effects, the early post-surgical period is characterized by the erosion of lower extremity muscle size and strength that cause further disability and slow functional recovery. While the detrimental effects of this period on muscle are widely recognized, the mechanisms underlying these adaptations are poorly understood and there are currently no widely-accepted clinical interventions to counter them

NCT ID: NCT03046095 Completed - Muscle Atrophy Clinical Trials

The Regulation of Human Skeletal Muscle Mass by Contractile Perturbation

HYPAT
Start date: May 1, 2017
Phase: N/A
Study type: Interventional

It is well known that periods of weight training lead to increases in skeletal muscle size and strength. In contrast, periods of inactivity such as bed rest or immobilization result in losses of skeletal muscle size and strength. However, individuals experience variable magnitudes of muscle size change in response to changes in mechanical tension, such that certain individuals experience large changes in muscle mass whereas others do not. What is not currently known, and will be the primary goal of the present investigation, is to determine whether individuals who gain the most muscle mass with exercise training also lose the most muscle when they are immobilized. The investigators hypothesize that individuals who gain the most muscle with training will also lose the most with immobilization.

NCT ID: NCT03035266 Completed - Knee Injuries Clinical Trials

The Effect of Blood Flow Restriction Training on Muscle Atrophy Following Knee Surgery

Start date: April 5, 2017
Phase: N/A
Study type: Interventional

The investigators will compare differences in quadriceps strength, leg girth, and functional outcome scores between two groups of patients after weeks 6 and 12 as well as 6 months following meniscus or articular cartilage repair/restoration requiring 6 weeks of non-weight bearing or limited weight bearing status in a brace at 0° degrees of knee extension. One group will receive BFR with standard post-operative rehabilitation for 12 weeks followed by the standard protocol progression for the remainder of the treatment program. The other group will receive standard post-operative rehabilitation without BFR for the duration of treatment program.

NCT ID: NCT03026985 Completed - Critical Illness Clinical Trials

Acute Skeletal Muscle Wasting and Relation to Physical Function in Patients Requiring ECMO

Start date: January 25, 2017
Phase: N/A
Study type: Observational

The purpose of this study is to describe the changes in quadriceps muscle size and quality over the first 10 days on extracorporeal membrane oxygenation (ECMO) using ultrasound imaging. This study will also examine the relationship between those changes and muscle strength and level of physical function at day 10 and day 20 after ECMO commencement.

NCT ID: NCT03012139 Completed - Metastatic Cancer Clinical Trials

Cancer-Associated Muscle Atrophy and Weakness: An Investigation of Etiology

Start date: January 2017
Phase:
Study type: Observational

This study is designed to gain a better understanding of the mechanisms leading to muscle wasting and metabolic abnormalities in skeletal muscle of cancer patients.

NCT ID: NCT02994030 Completed - Clinical trials for Duchenne Muscular Dystrophy

Biomarker for Duchenne Muscular Dystrophy

BioDuchenne
Start date: August 20, 2018
Phase:
Study type: Observational

International, multicenter, observational, longitudinal study to identify biomarker/s for Duchenne Muscular Dystropy (DMD) and to explore the clinical robustness, specificity, and long-term variability of these biomarker/s.

NCT ID: NCT02984332 Completed - Muscular Atrophy Clinical Trials

Timecourse of Immobilization Experiment

TIME
Start date: January 2016
Phase: N/A
Study type: Interventional

The effect of unilateral lower limb immobilisation over one week on muscle atrophy